Special Resource. Drugs to be Used with a Filter for Preparation and/or Administration



Similar documents
Filtration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010

Monoclonal antibody (mab) products are currently a fast

Reconstitution of Solutions

National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment

RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS

Use of the Injectable Medicines Guide website in clinical areas - IntraVENOUS medicine monographs (January 2013)

Gloucestershire Hospitals

MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No.

BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET

ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS

Hydration, IV Infusions, Injections and Vaccine Charge Process

Documentation Summary for Chemotherapy Administration, Nonchemotherapy Injections and Infusions

PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)

Understanding ph and Osmolarity. Marc Stranz, PharmD

Ward 29 guide to the safe preparation and administration of intravenous (IV) antibiotics at home

Good practice for the preparation of injectable medicines in clinical areas

Products for the Treatment of Factor VIII Deficiency

Date effective: Jan 2005 Date revised: June 2015

NOTICES DEPARTMENT OF HEALTH

INTRAVENOUS DRUG QUICKGUIDE

Medications or therapeutic solutions may be injected directly into the bloodstream

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only

Syringe. Product Usage Information: Precautions:

Classification of Hazardous Drugs by NIOSH

MEDICATION MANUAL Policy & Procedure

Chemotherapy Administration, Hydration and Therapeutic, Prophylactic, and Diagnostic Injections and Infusions

DRUG CALCULATIONS. Mathematical accuracy is a matter of life and death. [Keighley 1984]

MMA Drug Administration Coding Revisions

An introduction to High Risk Medications

Promoting safer use of injectable medicines

COMPOUNDING PHARMACY IN THE HOSPITAL SETTING SATURDAY/11:30AM-12:30PM

Policies & Procedures. ID Number: 1118

By Lawrence A. Trissel, B.S., R.Ph., FASHP. Modified from the original presentation March 9, 2006

It has been recommended that all

The Future of Monoclonal Antibodies Therapeutics: Innovation in Antibody Engineering, Key Growth Strategies and Forecasts to 2011

Recommendations for the Safe Use of Handling of Cytotoxic Drugs

PHARMACY TECHNICIAN COURSE DESCRIPTIONS

EDUCATOR S LESSON PLAN

Dilution and. Concentration. Chapter 10 TERMS OBJECTIVES % C X

LESSON ASSIGNMENT. After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio and proportion method.

Alert. Patient safety alert. Promoting safer use of injectable medicines. 28 March Action for the NHS and the independent sector

MISSISSIPPI BOARD OF NURSING IV THERAPY COURSE FOR THE EXPANDED ROLE LICENSED PRACTICAL NURSE COURSE OUTLINE

Illinois Valley Community College Nursing Program Math Questions

Illinois Department of Revenue Regulations TITLE 86: REVENUE CHAPTER I: DEPARTMENT OF REVENUE

Correct Coding for Infusions and Injections. Agenda. Supervision Levels. Regan Tyler, CPC, CPC-H, CPMA, CEMC, ACS-EM

Policy and Procedure Flushing and / or Blood withdrawal Aspiration Procedure For PICC Line and Midline Catheters

Pediatric Dosages CHAPTER 18 ALERT LEARNING OBJECTIVES

Administration of Medications & Fluids via a Peripheral Intravenous Cannula

A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO)

Helping to protect you from exposure to hazardous drugs

GUIDELINES FOR NUCLEAR PHARMACY TECHNICIAN TRAINING PROGRAMS

HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida

3% Sodium Chloride Injection, USP 5% Sodium Chloride Injection, USP

Basic Medication Administration Exam RN (BMAE-RN) Study Guide

GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION REGULATIONS RELATING TO ADMINISTRATION OF INTRAVENOUS THERAPY BY LICENSED NURSES

Chapter 1: Ohio Nursing Laws and Rules Defining Scopes of Practice

SECTION OF EMERGENCY MEDICAL SERVICES MINIMUM REQUIRED EQUIPMENT LIST PARAMEDIC

Sterilization methods and equipment Lab 1-2

Paramedic Pediatric Medical Math Test

Auvi-Q (epinephrine injection) 0.15mg and 0.3mg (Sanofi)

PROFESSIONAL BOARD FOR EMERGENCY CARE

Order Phenytoin dilantin ivpb rate when to order phenytoin level dilantin 30 mg

Bishop State Community College. Dosage Calculation Review Study Booklet

Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide

A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS

NOTICES. Approved and Required Medications Lists for Emergency Medical Services Agencies and Emergency Medical Services Providers

Monoclonal Antibodies

Non-Oral Routes of Drug Administration

Parenteral Administration

NURSING PRACTICE & SKILL

YAKUGAKU ZASSHI 126(4) (2006) 2006 The Pharmaceutical Society of Japan

A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL

PHARMACY TECHNICIAN SERIES

Indication: Posology: Indication: Posology:

Medication Calculation Practice Problems

CUESTA COLLEGE REGISTERED NURSING PROGRAM CRITICAL ELEMENTS

Aerospace Medical Association

Bayer HealthCare, LLC Sharps Disposal Submission to CalRecycle July 1, 2014

POSSIBLE NURSING DIAGNOSIS: Pain Potential for Infection / Infection Fluid volume deficit

LOS ANGELES COUNTY EMERGENCY MEDICAL SERVICES LOS ANGELES COUNTY EMT-I EXPANDED SCOPE OF PRACTICE

Coverage and Pricing. of Drugs That Can Be Covered Under. Part B and Part D

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

Needlestick Injury Prevention Assessment Tool

Pharmacy Technician Web Based Calculations Review

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

Administering Medications

Safe Medication Administration Preparation Guide C.O.R.E Essentials

0.9% Sodium Chloride Injection, USP In VIAFLEX Plastic Container

Beaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject

Read the following information carefully before attempting the examples and exercises. TABLETS Formula method. = No. of tablets to be given

ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol

Good practice for drug calculations

Calcium Folinate Ebewe Data Sheet

ONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place)

Effective: July 28, Arizona Prior Authorization Requirements Health Net Access, Inc.

Using a filter should not be difficult either.

Transcription:

Hospital Pharmacy Volume 42, Number 4, pp 378 382 2007 Wolters Kluwer Health, Inc. Special Resource Drugs to be Used with a Filter for Preparation and/or Administration Prepared by: Wolters Kluwer Health/Facts and Comparisons Date: March 9, 2007 Disclaimer: While every effort has been made to ensure the accuracy and completeness of the information presented in this chart, the reader is advised that the authors or Wolters Kluwer Health cannot be responsible for the currency of the information, for any errors or omissions, or for any consequences that may arise. The reader should consult the product package insert for the most up-to-date information. Abatacept (Orencia) Immunomodulator 0.2 to 1.2 micron Administer with an infusion set and a sterile nonpyrogenic, low-protein-binding filter. Abciximab (ReoPro) Glycoprotein IIb/IIIa 0.2 or 0.22 micron For a bolus injection, filter prior to inhibitor administration; for continuous infusion, filter either upon admixture (using a sterile, nonpyrogenic, low-protein-binding filter) or upon administration (using an inline, sterile, nonpyrogenic, low-protein-binding filter). Agalsidase beta Enzyme 0.2 micron Do not use filter needles during the preparation (Fabrazyme) of the infusion; diluted solution should be filtered through an inline low-protein-binding filter during administration. Alglucosidase alfa Enzyme 0.2 micron Do not use filter needles during the preparation (Myozyme) of the infusion; diluted solution should be filtered through an inline low-protein-binding filter during administration. Alpha-1 Respiratory enzyme See individual proteinase package inserts inhibitor (eg, Prolastin, Aralast, Zemaira) Amiodarone Antiarrhythmic agent Not specified Use a 0.2 micron inline filter during (Cordarone) administration; recommended by manufacturer. Another source suggests no significant loss of drug potency with the use of a 0.22 micron cellulose ester membrane filter. 1,2 Amphotericin B Antifungal agent 1 micron or larger Filter may be used during administration. desoxycholate mean pore (Amphocin, diameter (inline Fungizone) membrane filter) Antihemophilic Antihemophilic agent Not specified Use filtered needle provided by manufacturer. factor (eg, Adurate, Kogenate) Antihemophilic Antihemophilic factor Not specified Use filter for withdrawal from the vial. factor/von combination Willebrand Factor Complex (Humate P) 378 Volume 42, April 2007

Antithymocyte Immune globulin 0.22 micron globulin inline filter (Thymoglobulin) Antithrombin III Antithrombin agent Not specified Use filter needle provided by manufacturer. (Thrombate III) Asparaginase Antineoplastic agent 5 micron Filter during intravenous (IV) administration. (Elspar) Botulism immune Immune globulin 18 micron Use inline or syringe-tip sterile, disposable filter. globulin IV (BabyBIG) Busulfan (Busulfex) Antineoplastic agent 5 micron Do not use polycarbonate syringes or polycarbonate filter needles with busulfan; only use the 5 micron nylon 1 filter needle provided; use one filter per ampule. Cetuximab (Erbitux) Monoclonal antibody 0.22 micron inline filter Citric acid, glucono- Urinary irrigant Not specified After thorough mixing, filter the solution delta-lactone, and through a coarse filter. magnesium carbonate (Renacidin) Cladribine (Leustatin) Antineoplastic agent 0.22 micron When preparing the 7-day infusion solution, both cladribine and the diluent should be passed through a sterile disposable hydrophilic syringe filter as each solution is being introduced into the infusion reservoir. Clofarabine (Clolar) Antineoplastic agent 0.2 micron Filter prior to dilution. Cytomegalovirus Immune globulin 15 micron inline A 0.2 micron filter is also acceptable. immune globulin IV, filter human (CytoGam) Digoxin immune Detoxification agent 0.22 micron Fab (Digibind) membrane filter Epoprostenol sodium Vasodilator 0.22 micron An inline filter was used during clinical trials. (Flolan) Ferumoxides Diagnostic agents 5 micron (Feridex IV) Galsulfase Enzyme 0.2 micron Do not use a filter during preparation of the (Naglazyme) solution; administer with a polyvinyl chloride (PVC) infusion set equipped with an inline, lowprotein-binding filter. Gemtuzumab Monoclonal antibody 1.2 micron terminal Can be given through central or peripheral ozogamicin filter line; administer through a separate line (Mylotarg) equipped with a low-protein-binding, 0.2 to 1.2 micron terminal filter; manufacturer states: The following filter membranes are qualified: 0.22 or 1.2 micron polyether sulfone (PES) Supor; 1.2 micron acrylic copolymer hydrophilic filter (Versapor); 0.8 micron cellulose mixed ester (acetate and nitrate) membrane; 0.2 micron cellulose acetate membrane. 1 Hemin (Panhematin) Hemin agent 0.45 micron or smaller terminal filter Hospital Pharmacy 379

Hyaluronidase Enzyme 5 micron Use a filter needle when withdrawing the powder for reconstituted solution from the vial. injection (Vitrase) Idursulfase Enzyme 0.2 micron Filter to be used with an infusion set. (Elaprase) Imiglucerase Enzyme 0.2 micron Diluted solution may be filtered through an (Cerezyme) inline, low-protein-binding filter during administration. Immune Immune globulin See individual globulin IV package inserts (eg, Gammagard, Flebogamma) In-111 ibritumomab Radioimmunotherapeutic 0.22 micron A low-protein-binding filter should be inline tiuxetan and Y-90 monoclonal antibody between the syringe and infusion port prior ibritumomab tiuxetan to injection of each component. (Zevalin) Infliximab (Remicade) Monoclonal antibody 1.2 micron or smaller inline filter Inulin Diagnostic agent Not specified Administer through a filter. Itraconazole Antifungal agent Not specified Use infusion set with filter provided by the (Sporanox) manufacturer. Lansoprazole Proton pump inhibitor 1.2 micron Administer using inline filter provided. (Prevacid IV) Laronidase Enzyme 0.2 micron Do not use a filter during preparation of the (Aldurazyme) solution; administer with a PVC infusion set equipped with an inline, low-protein-binding filter. Lymphocyte Immune globulin 0.2 to 1 micron immune globulin, antithymocyte globulin (Atgam) Mafenide Topical burn preparation 0.22 micron Filter reconstituted solution prior to use; topical (Sulfamylon) use only. Mannitol Osmotic diuretic 5 micron inline filter To be used when infusing concentrated mannitol (20% or more). Methacholine Diagnostic agent 0.22 micron A sterile, bacterial-retentive filter should be used (Provocholine) when transferring a solution from each vial (at least 2 ml) to a nebulizer; initial use only. Morphine sulfate Opioid 0.22 micron Prepare soluble tablets in sterile water and filter soluble tablets for prior to administration. injection Morphine sulfate Opioid 5 micron or smaller Filter through a microfilter before injecting for intrathecal into the microinfusion device; intrathecal use administration only. (Infumorph) Muromonab-CD3 Monoclonal antibody 0.2 or 0.22 micron Draw solution into a syringe through a low- (Orthoclone OKT3) protein-binding filter. Paclitaxel (Taxol, Antineoplastic agent 0.22 micron or Administer through an inline filter; use of a Onxol) smaller filter is not recommended for Abraxane. Panitumumab Monoclonal antibody 0.2 or 0.22 micron Administer by an IV infusion pump using a (Vectibix) low-protein-binding inline filter. 380 Volume 42, April 2007

Pentetate calcium Detoxification agent Not specified May be filtered using a sterile filter if particles trisodium are seen subsequent to opening of the ampule. Phenytoin Anticonvulsant Not specified Although not recommended, some studies sodium, (inline filter) ndicate that an IV infusion of phenytoin may parenteral be feasible if proper precautions are observed, such as a suitable vehicle (eg, 0.9% sodium chloride or Ringer s lactated injection), appropriate concentration, preparing the infusion shortly before administration, and using an inline filter; according to most studies, a 0.22 micron inline filter is required 1,3 ; phenytoin sodium (250 mg/5ml in a 5 ml syringe) was filtered at a rate of 1 ml/min through a 5 micron stainless steel depth filter without significant reduction in potency. 2 Ranibizumab Vascular endothelial 5 micron Withdraw the solution from the vial through a (Lucentis) growth factor 5-micron, 19-gauge filter needle attached to a antagonist 1 ml tuberculin syringe; for intravitreal injection only. Respiratory Immune globulin Larger than An inline filter may be used for RSV-IGIV syncytial virus 15 micron infusions. immune globulin, IV (RSV-IVIG) (RespiGam) Streptokinase Thrombolytic enzyme 0.8 micron or larger (Streptase) Thiotepa Antineoplastic agent 0.22 micron Filter prior to administration; polysulfone (Thioplex) membrane (Gelman s Sterile Acrodisc, Single Use) or triton-free mixed ester of cellulose/pvc (Millipore s MILLEX-GS Filter Unit) are recommended by the manufacturer. Tositumomab Radioimmunotherapeutic 0.22 micron Administer via IV tubing set with an inline filter. and iodine 131 monoclonal antibody The same IV tubing set and filter must be used I-tositumomab throughout the entire dosimetric or therapeutic (Bexxar) step; a change in filter can result in loss of drug. Vaccinia immune Immune globulin 0.22 micron Administer VIGIV via an IV catheter with an globulin IV (VIGIV) administration set that contains an inline filter. Verteporfin Ophthalmic 1.2 micron Administer using a syringe pump and inline (Visudyne) phototherapy agent filter; use of an inline filter (pore size 0.22 to 1.2 microns) is required for administration. 1 a Note: For consistency, the term micron is used to encompass all terms meaning the same (eg, micrometer, mcm, mm) References 1. Gahart BL, Nazareno AR. Intravenous Medications: A Handbook for Nurses and Health Professionals. 23rd ed. St. Louis, MO: Mosby Elsevier; 2006. 2. Trissel LA. Handbook on Injectable Drugs. 4th ed. Bethesda, Maryland: American Society of Health-System Pharmacists; 2007. 3. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2007. Available from Wolters Kluwer Health, Inc. Accessed March 9, 2007. 381 Volume 42, April 2007

INDEX TO ADVERTISERS American Health Packaging Pravastatin...................................321 Hospira Hospira.......................................79 Hospira Worldwide Magnesium Sulfate..............................307 Janssen Pharmaceutical Invega..........................288a 290, 368a 370 King Pharmaceuticals Thrombin JMI..............................300 302 KV Pharmaceuticals InveAmp.....................................311 Medi-Dose, Inc. Unit Dose Packaging............................285 Ortho Biotech Procrit....................................Cover 4 Pfizer, Inc. Geodon IM................................315 316 Schering Plough Noxafil...........................293 296, 361 364 TEVA Pharmaceuticals USA Azithromycin..................................281 Wyeth Pharmaceuticals Tygacil.............................Cover 2, 273-274 382 Volume 42, April 2007